| Literature DB >> 34267774 |
Alvaro Soler-Garzón1, Phillip E McClean2, Phillip N Miklas3.
Abstract
Bean common mosaic necrosis virus (BCMNV) is a major disease in common bean (Phaseolus vulgaris L.). Host plant resistance is the primary disease control. We sought to identify candidate genes to better understand the host-pathogen interaction and develop tools for marker-assisted selection (MAS). A genome-wide association study (GWAS) approach using 182 lines from a race Durango Diversity Panel (DDP) challenged by BCMNV isolates NL-8 [Pathogroup (PG)-III] and NL-3 (PG-VI), and genotyped with 1.26 million single-nucleotide polymorphisms (SNPs), revealed significant peak regions on chromosomes Pv03 and Pv05, which correspond to bc-1 and bc-u resistance gene loci, respectively. Three candidate genes were identified for NL-3 and NL-8 resistance. Side-by-side receptor-like protein kinases (RLKs), Phvul.003G038700 and Phvul.003G038800 were candidate genes for bc-1. These RLKs were orthologous to linked RLKs associated with virus resistance in soybean (Glycine max). A basic Leucine Zipper (bZIP) transcription factor protein is the candidate gene for bc-u. bZIP protein gene Phvul.005G124100 carries a unique non-synonymous mutation at codon 14 in the first exon (Pv05: 36,114,516 bases), resulting in a premature termination codon that causes a nonfunctional protein. SNP markers for bc-1 and bc-u and new markers for I and bc-3 genes were used to genotype the resistance genes underpinning BCMNV phenotypes in the DDP, host group (HG) differentials, and segregating F3 families. Results revealed major adjustments to the current host-pathogen interaction model: (i) there is only one resistance allele bc-1 for the Bc-1 locus, and differential expression of the allele is based on presence vs. absence of bc-u; (ii) bc-1 exhibits dominance and incomplete dominance; (iii) bc-1 alone confers resistance to NL-8; (iv) bc-u was absent from HGs 2, 4, 5, and 7 necessitating a new gene symbol bc-u d to reflect this change; (v) bc-u d alone delays susceptible symptoms, and when combined with bc-1 enhanced resistance to NL-3; and (vi) bc-u d is on Pv05, not Pv03 as previously thought. These candidate genes, markers, and adjustments to the host-pathogen interaction will facilitate breeding for resistance to BCMNV and related Bean common mosaic virus (BCMV) in common bean.Entities:
Keywords: Phaseolus vulgaris; autophagy; hypersensitive response; marker-assisted selection; potyvirus; receptor-like kinases; synteny; transcription factors
Year: 2021 PMID: 34267774 PMCID: PMC8277298 DOI: 10.3389/fpls.2021.699569
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Primers were used to generate markers for bc-1, bc-ud, I, and bc-3 genes conditioning resistance to Bean common mosaic necrosis virus (BCMNV) and Bean common mosaic virus (BCMV).
| BCMNV resistance genes | ID marker | Sequence | Ta (°C) | Chr | Position (G19833v2.1) | Sense | Allele Resistant | Allele Susceptible | |
|---|---|---|---|---|---|---|---|---|---|
| | S03_4203361 | gcgggcTGGTCAGTTTGTCTTCCCTAACT | 60 | Pv03 | 4,203,361 | + | T | A | |
| TGCAGAAGAGCTCAACTCGAAG | |||||||||
| gcgggcagggcggcGGTCAGTTTGTCTTCCCTAACA | |||||||||
| | Pvbzip1_A_C | gcgggcTAGGAGAACTTGGTTTGTCTGAGTA | 66 | Pv05 | 36,114,516 | + | A | C | |
| GCACTCCATAAGGGATGTGGT | |||||||||
| gcgggcagggcggcGGAGAACTTGGTTTGTCTGAGTC | |||||||||
| | gcgggcCAAAGTGCTAGAGGCATGATCA | 58 | Pv02 | 48,908,259 | + | T | A | ||
| TGGTTATCATTCATTGTGAAGTCAATG | |||||||||
| gcgggcagggcggcCAAAGTGCTAGAGGCATGATCT | |||||||||
| | PveIF4E1,3,4 _PveIF4E2 | gcgggcCAATCTTATGCTTGAAGCAGTGAAAGT | 69 | Pv06 | 27,204,768 | − | G | A | |
| ATTTACAATAACATTCACCACCCGAGCAA | |||||||||
| gcgggcagggcggcAATCTTATGCTTGAAGCAGTGAAAGC | |||||||||
Phenotypic reactions to BCMNV isolates NL-8 and NL-3observed in Durango Diversity Panel (DDP; 182 lines), classified into two major groups: recessive I gene vs. dominant I gene, with four and five phenotype sub-categories, respectively.
| Group | DDP lines no. | NL-8 | NL-3 |
| Lines no. | Lines % |
|---|---|---|---|---|---|---|
| | 96 (four categories) | No Symptoms | mild Mosaic | 48 | 26.4 | |
| Mosaic | Mosaic | 17 | 9.3 | |||
| delayed Mosaic | Mosaic | 16 | 8.8 | |||
| No Symptoms | Mosaic | 15 | 8.2 | |||
| | 61 (five categories) | Top Necrosis | Top Necrosis | 31 | 17.0 | |
| delayed Top Necrosis | Top Necrosis | 11 | 6.0 | |||
| Vein Necrosis | Vein Necrosis | 9 | 4.9 | |||
| Vein Necrosis | Top Necrosis | 8 | 4.4 | |||
| Necrotic Local Lesion | Necrotic Local Lesion |
| 2 | 1.1 | ||
| Misc. | 25 | No Symptoms | No Symptoms |
| 12 | 6.6 |
| No Symptoms | No Symptoms | 6 | 3.3 | |||
| Segregating | Segregating | Segregating | 7 | 3.8 |
Twenty-five miscellaneous lines were not included in the analyses. Subsequently, the DDP was assayed with SNP markers to detect bc-1, bc-ud, I, and bc-3 genes.
Presence of the bc-1, bc-ud, I, and bc-3 genes based on temperature melting (Tm)-shift SNP marker assays (as shown in Table 1).
Presence of the bc-22 allele based on published information.
Figure 1Manhattan plots of common mosaic necrosis virus (BCMNV) resistance in DDP. The gray horizontal line represents the genome-wide significance threshold of p = 3.98 × 10−8. (A) genome-wide association study (GWAS) using lines exhibiting mild mosaic (mM) and lines with mosaic (M) symptoms inoculated with NL-3 strain, two strong associations on Pv03 (bc-1) and Pv05 (bc-ud). (B) GWAS using lines with no symptoms (NS) compared with lines showing mosaic (M) symptoms against NL-8 strain, peak detected on Pv03 (bc-1). Bottom: Density bar (color-coded) showing genome distribution of 1,269,044 biallelic SNPs within 1 Mb window size in the DDP.
Figure 2bc-1 regional marker-trait associations plot depicting the receptor-like protein kinases (RLK) candidate genes (arrows) for bc-1 inside the dotted box rectangle.
Synteny analysis between common bean and soybean comparing bc-1 and Rsv4 candidate genes (bold type), respectively.
| Chromosome location | BLASTp | Annotation | ||
|---|---|---|---|---|
| Phvul.003G038300 | Pv03: 4,023,174–4,028,058 | Glyma.02G122700 | 0.0; 66.9% | 18S Pre-Ribosomal assembly protein GAR2-related protein |
| Phvul.003G038400 | Pv03: 4,121,926–4,126,390 | Glyma.02g122500 | 0.0; 94.2% | ACT domain repeat 5 |
| Phvul.003G038500 | Pv03: 4,139,554–4,140,060 | Glyma.02g122400 | 8.0E-40; 81.7% | Putative unknown protein |
| Phvul.003G038600 | Pv03: 4,151,102–4,157,419 | Glyma.02g122200 | 0.0; 70.2% | Chaperone DNAJ-domain superfamily protein |
|
|
|
|
|
|
|
|
|
|
|
|
| Phvul.003G038900 | Pv03: 4,215,776–4,217,396 | Glyma.02g121800 | 1.2E-154; 86.3% | Adenine nucleotide alpha hydrolases-like superfamily protein |
| Phvul.003G039000 | Pv03: 4,225,490–4,229,239 |
| 0.0; 76.0% | MIF4G domain-containing protein/MA3 domain-containing protein |
| Phvul.003G039100 | Pv03: 4,232,478–4,234,069 | Glyma.02g121700 | 8.7E-28; 44.6% | RING/U-box Zinc finger, C3HC4 type protein |
These orthologous genes in soybean for Phvul.003G039000 are on different chromosomes.
Candidate gene (bold type) for the bc-ud gene region.
| Phaseolus vulgaris G19833 v2.1 | Chromosome location | Annotation |
|---|---|---|
| Phvul.005G122700 | Pv05: 36,000,235–36,000,933 | Senescence regulator |
| Phvul.005G122800 | Pv05: 36,006,618–36,009,521 | FAMILY NOT NAMED |
| Phvul.005G122900 | Pv05: 36,012,213–36,012,827 | Cupin domain |
| Phvul.005G123100 | Pv05: 36,031,013–36,035,680 | N-carbamoylputrescine amidase (aguB) |
| Phvul.005G123200 | Pv05: 36,039,621–36,040,692 | Fantastic Four meristem regulator (FAF) |
| Phvul.005G123300 | Pv05: 36,043,640–36,047,570 | Rho GTPase activating protein with PAK-box / P21-Rho-binding domain |
| Phvul.005G123400 | Pv05: 36,053,256–36,055,519 | Calcium-binding EF-hand family protein |
| Phvul.005G123600 | Pv05: 36,059,079–36,062,903 | Glycosyl hydrolase superfamily protein |
| Phvul.005G123500 | Pv05: 36,060,209–36,060,364 | No annotation |
| Phvul.005G123700 | Pv05: 36,074,164–36,076,099 | Ribosomal protein L1p/L10e family |
| Phvul.005G123800 | Pv05: 36,087,411–36,087,806 | No annotation |
| Phvul.005G123900 | Pv05: 36,094,573–36,097,466 | Homeodomain-like superfamily protein/MYB-CC type trans-factor, LHEQLE motif |
| Phvul.005G124000 | Pv05: 36,104,915–36,107,979 | No annotation |
|
|
|
|
| Phvul.005G124200 | Pv05: 36,125,362–36,127,721 | Basic-leucine zipper (bZIP) transcription factor family protein |
Figure 3Candidate genes in bc-u region detected by GWAS: (A) coding variants distributed across gene models for the bc-ud gene region, and (B) Phvul.005G124100 basic Leucine Zipper (bZIP) gene-based marker-trait associations plot.
Figure 4Regional association plot displaying GWAS results and candidate genes for I gene: (A) I gene regional marker-trait associations and linkage disequilibrium plots, and (B) alignment of the amino acid sequences of NBS-LRR cluster proteins.
Single-nucleotide polymorphism genotyping of BCMNV and BCMV host differential genotypes.
| Line | Genepool | Host Group | Proposed Resistance Genotype | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pv02: 48,908,259 | Pv03: 4,203,361 | Pv03: 4,204,238 | Pv05: 36,114,516 | Pv06: 27,204,768 | ||||||
| Dubbele Witte | Mesoamerican | 1 | none | M | M | − | − | − | − | − |
| Sutter Pink | Durango | 1 | none | M | M | − | − | − | − | − |
| Bountiful | Andean | 1 |
| M | M | − | + | + | − | − |
| Stringless Green Refugee (SGR) | Andean | 1 |
| M | M | − | + | + | − | − |
| Poncho (DDP041) | Durango | 1 | dM | M | − | − | − | + | − | |
| Imuna | Andean | 2 | NS | M | − | + | + | − | − | |
| Redlands Greenleaf C (RGC) | Andean | 2 | NS | M | − | + | + | − | − | |
| UI-59 (DDP076) | Durango | 3 | NS | mM | − | + | + | + | − | |
| Olathe | Durango | 3 | NS | mM | − | + | + | + | − | |
| Common Red (DDP067) | Durango | 3 | NS | mM | − | + | + | + | − | |
| Redlands Greenleaf B (RGB) | Andean | 3 |
| NS | mM | − | + | + | − | − |
| Michelite 62 | Mesoamerican | 4 | M | M | − | − | − | − | − | |
| Sanilac | Mesoamerican | 4 | M | M | − | − | − | − | − | |
| UI-111 (DDP077) | Durango | 4 | M | M | − | − | − | − | − | |
| UI-34 | Durango | 4 | M | M | − | − | − | − | − | |
| UI-114 (DDP078) | Durango | 5 |
| NS | M | − | + | + | − | − |
| Othello (DDP109) | Durango | 6 | NS | NS | − | + | + | + | − | |
| GN-31 | Durango | 6 | NS | NS | − | + | + | + | − | |
| UI-129 | Durango | X |
| NS | M | − | + | + | − | − |
| IVT-7214 | Mesoamerican | 7 |
| NS | NS | − | − | − | − | + |
| Black Turtle I | Mesoamerican | 8 | TN | TN | + | − | − | − | − | |
| Widusa | Andean | 8 | TN | TN | + | − | − | − | − | |
| Gemini (DDP152) | Durango | 8 | dTN | TN | + | − | − | + | − | |
| Jubila | Andean | 9a | VN | VN+ | + | + | + | − | − | |
| Topcrop | Andean | 9b | VN | TN | + | + | + | − | − | |
| Amanda | Andean | 10 |
| VN | VN | + | + | + | − | − |
| Beryl (DDP055) | Durango | 10 | VN | VN | + | + | + | + | − | |
| 92US-1006 (DDP108) | Durango | 11 | LLN | LLN | + | − | − | + | − | |
| IVT-7223 | Mesoamerican | 11 | LLN | LLN | + | − | − | + | − | |
| TARS-VR-8S | Mesoamerican | 12 | NS | NS | + | − | − | + | + | |
| USCR-7 | Andean | 12 | NS | NS | + | + | + | − | + | |
| USLK-3 | Andean | 12 | NS | NS | + | + | + | + | + | |
| Raven | Mesoamerican | 12 | NS | NS | + | − | − | − | + |
NS, no symptoms; VN, vein necrosis; VN+, vein necrosis on upper trifoliolate leaves; NLL, local necrotic lesions; TN, top necrosis; dTN, delayed top necrosis; M, mosaic; mM, mild mosaic; dM, delayed mosaic.
SNP markers developed in this study.
SCAR marker developed by Miklas et al. (2000).
SNP variant identified by Hart and Griffiths (2013) but modified to the Tm-shift SNP genotyping method.
bc-1 for these HG-1 cultivars was unexpected and will require further investigation.
bc-? indicates a helper gene other than bc-ud and work characterizing these other genes is in progress.
Phenotypic reactions to BCMNV NL-8 and NL-3 strains, pooled across F2:3 families from multiple crosses with the same F2 genotype based on SNP genetic markers linked with I (S02_48908259), bc-1 (S03_4203361), and bc-ud (Pvbzip1_A_C) genes.
| Genotypes/Virus strain | F2 progenitor SNP markers | Number of F2:3 plants | Non | | Observed ratio | Probability | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | dM | mM | NS | TN | dTN or VN+ | VN | |||||
| NL-8 |
| 42 | 42 | 1:0 | 0.00 | ||||||
| +/−/+ | 118 | 118 | 0:1 | 0.00 | |||||||
| +/+/− | 63 | 63 | 0:1 | 0.00 | |||||||
| +/+/+ | 122 | 122 | 0:1 | 0.00 | |||||||
| +/+/H | 55 | 55 | 0:1 | 0.00 | |||||||
| +/H/+ | 80 | 25 | 55 | 1:3 | 1.67 | ||||||
| +/H/− | 40 | 14 | 26 | 1:3 | 2.13 | ||||||
| +/−/H | 39 | 31 | 8 | 3:1 | 0.42 | ||||||
| +/H/H | 36 | 7 | 3 | 26 | 3:1:12 | 0.30 | |||||
| H/+/+ | 16 | 3 | 13 | 1:3 | 0.33 | ||||||
| H/−/+ | 21 | 2 | 19 | 1:3 | 2.68 | ||||||
| −/H/+ | 18 | 4 | 10 | 4 | 1:2:1 | 0.22 | |||||
| H/H/+ | 19 | 0 | 1 | 3 | 5 | 10 | 1:2:1:3:9 | 5.80 | |||
|
|
|
|
|
|
|
|
|
|
|
| |
| NL-3 | +/−/− | 26 | 26 | 1:0 | 0.00 | ||||||
| +/−/+ | 109 | 109 | 1:0 | 0.00 | |||||||
| +/+/− | 55 | 55 | 1:0 | 0.00 | |||||||
| +/+/+ | 117 | 117 | 0:1 | 0.00 | |||||||
| +/+/H | 52 | 14 | 22 | 16 | 1:2:1 | 1.38 | |||||
| +/H/+ | 76 | 23 | 29 | 24 | 1:2:1 | 4.29 | |||||
| +/H/− | 37 | 37 | 1:0 | 0.00 | |||||||
| +/−/H | 36 | 36 | 1:0 | 0.00 | |||||||
| +/H/H | 35 | 12 | 22 | 1 | 7:8:1 | 2.52 | |||||
| H/+/+ | 18 | 8 | 10 | 1:3 | 3.63 | ||||||
| H/−/+ | 19 | 4 | 15 | 1:3 | 0.16 | ||||||
| −/H/+ | 15 | 3 | 9 | 3 | 1:2:1 | 0.60 | |||||
| H/H/+ | 20 | 1 | 5 | 3 | 3 | 7 | 1 | 1:2:1:3:6:3 | 7.20 | ||
|
|
|
|
|
|
|
|
|
|
|
| |
+ and −, indicates homozygous for the resistance and susceptible marker alleles, respectively. H indicates heterozygotes.